Growing biotech focus uniQure operates within the biotechnology research industry with a specialization in gene therapy, presenting opportunities to collaborate on advanced genetic treatments and innovative drug development projects.
Recent stock concerns Ongoing investigations and a significant recent stock decline indicate potential vulnerability, creating an opportunity for service providers to offer legal, financial, or investor relations support.
Stable funding base With accumulated funding of 300 million dollars and a revenue range of 10 to 25 million dollars, uniQure shows a healthy financial position, supporting expansion initiatives and the adoption of new technologies.
Technology utilization The company's diverse tech stack including cloud, analytics, and research platforms suggests a need for advanced IT and infrastructure services to optimize R&D processes.
Market momentum Given the company's moderate buy consensus and recent stock fluctuations, there is potential to engage in strategic partnerships, investor relations, and market positioning solutions to strengthen shareholder confidence.
$250M$500M
$10B
$10B
$10B
$10B
$1B$10B
$250M$500M
$10B
$10B
$1B$10B
$50M$100M
$1B$10BuniQure uses 8 technology products and services including Adobe, SAS/GRAPH, AlphaSense, and more. Explore uniQure's tech stack below.
| uniQure Email Formats | Percentage |
| F.Last@uniqure.com | 94% |
| Last.First@uniqure.com | 4% |
| First.Last@uniqure.com | 1% |
| FLast@uniqure.com | 1% |
Biotechnology ResearchNorth Holland, Netherlands201-500 Employees
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
Company Overview
Media & News
Funding & FinancialsuniQure has raised a total of $300M of funding over 9 rounds. Their latest funding round was raised on Sep 25, 2025 in the amount of $300M.
uniQure's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsuniQure has raised a total of $300M of funding over 9 rounds. Their latest funding round was raised on Sep 25, 2025 in the amount of $300M.
uniQure's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com